Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hisayuki Tachibana"'
Autor:
Rei Yasukawa, Takuji Inagaki, Jun Horiguchi, Tsuyoshi Miyaoka, Haruo Seno, Hisayuki Tachibana, Tsuruhei Sukegawa
Publikováno v:
International journal of psychiatry in clinical practice. 9(1)
We report the case of a 58-year-old female without a history of psychosis or epilepsy presenting with abrupt late-onset persistent visual hallucinations that had prominent epileptiform discharges with a diffuse sharp and slow wave complex on electroe
Autor:
Kenji Imaoka, Kiyoshi Doi, Touji Matsushita, Kousuke Komatsubara, Etsuo Fukuma, Junji Takasu, Shuusaku Kuba, Yasunori Uchida, Atsushi Ihara, Tokuo Sugihara, Ken Watanabe, Itsuyuki Koga, Hiroshi Inoue, Hisayuki Tachibana
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 22:661-671
A powder preparation of the nicergoline “Sermion®” (TA-079 powder, containing 5mg of nicergoline in a 0.5g pouch) was administered to 29 patients with mild to moderate dementia due to cerebrovascular disease (15mg/day for eight weeks), and its e
Autor:
Takuji Inagaki, Jun Horiguchi, Ken Tsubouchi, Rei Yasukawa, Tsuyoshi Miyaoka, Takahiro Maeda, Takumi Mihara, Shoichi Mizuno, Yoshiko Shimizu, Hisayuki Tachibana, Jun Uegaki
Publikováno v:
The journal of ECT. 19(3)
SUMMARY A 61-year-old patient with major depression and selective serotonin reuptake inhibitor-induced bruxism was successfully treated with a course of bilateral electroconvulsive therapy. Both the depressive symptoms and bruxism completely remitted
Autor:
Tsuyoshi Miyaoka, Haruo Seno, Motoi Itoga, Ryutaro Ohshiro, Takuji Inagaki, Jun Horiguchi, Hisayuki Tachibana
Publikováno v:
The Journal of Clinical Psychiatry. 62:58-59
Depression and anxiety are frequently undiagnosed and untreated in cancer patients, resulting in a significant negative impact on quality of life and disease outcome. Furthermore, although effective therapies for depression and anxiety are available,
Autor:
Yoichi Nakazawa, Masatoshi Tanaka, Tatayu Kotorii, Nobuya Ogawa, Katsumi Inoue, Kazutoyo Inanaga, Hisayuki Tachibana, Masachika Oshima
Publikováno v:
Psychiatry and Clinical Neurosciences. 29:123-143
Publikováno v:
The Kurume Medical Journal. 18:161-168
In three cases of schizophrenia, ill for three-six years with no sign of remission under various psychopharmacotherapies, L-Dopa was used with the major tranquilizers which had previously been used. Subsequently, remarkable recovery was noted. The te
Publikováno v:
Psychiatry and Clinical Neurosciences. 27:223-230
Summary To investigate the relationship between REM sleep and the central catecholamine in man, L-DOPA 1,000 mg was orally ad ministered to five normal young adults and its effects were investigated on their REM sleep. No effect of L-DOPA 1,000 mg wa
Publikováno v:
The Kurume Medical Journal. 20:45-55
A female patient aged 66 years began to show involuntary movement of head at about the age of 40, which aggravated gradually. Impairment of memory and pururitic skin disease appeared since about 60 years. She was admitted to a hospital at the age of
Publikováno v:
Psychiatry and Clinical Neurosciences. 26:145-157
Summary L-Dopa was administered to 84 cases of schizophrenia (55 male, 29 female) together with major tranquilizers which had been given previously. 1) Patients suffering from lack of spontaneity, abulia, apathy, and disturbance of rapport were chose
Publikováno v:
The Journal of nervous and mental disease. 161(1)
In subjecting 14 healthy university students to partial differential rapid eye movement (REM) sleep deprivation (PDRD), the compensatory rebound of REM sleep during the next night was determined, and showed fairly substantial individual differences i